BACKGROUND
Following reperfusion in ST segment elevation myocardial infarction (STEMI), continuous
ECG monitoring is strongly recommended for the first 24-48 hours, the highest at-risk
period for an actionable arrhythmia (AA). Beyond this time-frame, the incident rate
of an AA and the role of continued telemetry is unclear.
METHODS AND RESULTS
Between Dec 2019 and Mar 2020 (interrupted by COVID-19), we aimed to prospectively
quantify the risk of an AA in a consecutive low-risk STEMI cohort treated within a
single PCI-network of care (Royal University Hospital, Saskatoon). Patients presenting
with cardiogenic shock, cardiac arrest or acute decompensated heart failure were excluded;
additionally, excluded were patients treated medically without reperfusion. The primary
outcome included the occurrence of an AA following discharge from the coronary care
unit (CCU); an AA was defined as any of the following: >3 seconds asystole; high grade
block; ventricular fibrillation; >15 beats ventricular tachycardia; atrial fibrillation
with rapid ventricular response; and >15 beats supraventricular tachycardia. Patients
with a history of any of these arrhythmias was also excluded. Key secondary outcomes
included 30-day all-cause mortality and re-hospitalization. Continuous variables are
presented as mean (±SD), and categorical variables as proportions. Of the 85 patients
meeting eligibility criteria, 82 provided informed consent and their baseline demographics
are presented in Table 1. The mean (±sd) durations of CCU and cumulative in-hospital
length of stays were 2 (±0.81) days and 3.8 (±1.4) days, respectively. Two-thirds
(n=54) had been treated with primary PCI, the rest with a fibrinolytic pharmaco-invasive
strategy. The infarct-related territory was distributed as: anterior 34% and inferior
49%; significant stenoses (>70% non left main or >50% left main) in the non-infarct
related territory were identified in 45%. Only 1/82 (1.2%) had an AA following CCU
discharge, new onset atrial fibrillation not identified within the first 48 hours
of presentation. All 82 patients survived to hospital discharge, and the 30-day rates
of all-cause mortality and re-hospitalization were 1% and 10%, respectively.
CONCLUSION
In this small, single-center, observational analysis of contemporarily treated low-risk
STEMI patients, the risk of an AA beyond 48 hours appears to be very small. The practice
of universally monitoring all low-risk STEMI patients until hospital discharge needs
to be better defined.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2021 Published by Elsevier Inc.